The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Constipation Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Constipation refers to bowel movements that are infrequent or hard to pass. The stool is often hard and dry. Other symptoms may include abdominal pain, bloating, and feeling as if one has not completely passed the bowel movement.
The global Constipation Treatment market size is expected to reach US$ 8330.8 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Constipation Treatment in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Constipation Treatment market. Chronic Idiopathic Constipation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Irritable Bowel Syndrome with Constipation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Constipation Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Constipation Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Constipation Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Constipation Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Constipation Treatment covered in this report include Takeda, SGYP, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Abbott, AstraZeneca, Cosmo Pharmaceuticals, Sanofi and Daewoong, etc.
The global Constipation Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
SGYP
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Daewoong
Bayer
Prestige Brands
Janssen Pharmaceutical
Shionogi
Albireo Pharma
Renexxion
Global Constipation Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Constipation Treatment market, Segment by Type:
Chronic Idiopathic Constipation
Irritable Bowel Syndrome with Constipation
Opioid Induced Constipation
Global Constipation Treatment market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Constipation Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Constipation refers to bowel movements that are infrequent or hard to pass. The stool is often hard and dry. Other symptoms may include abdominal pain, bloating, and feeling as if one has not completely passed the bowel movement.
The global Constipation Treatment market size is expected to reach US$ 8330.8 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Constipation Treatment in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Constipation Treatment market. Chronic Idiopathic Constipation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Irritable Bowel Syndrome with Constipation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Constipation Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Constipation Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Constipation Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Constipation Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Constipation Treatment covered in this report include Takeda, SGYP, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Abbott, AstraZeneca, Cosmo Pharmaceuticals, Sanofi and Daewoong, etc.
The global Constipation Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
SGYP
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Daewoong
Bayer
Prestige Brands
Janssen Pharmaceutical
Shionogi
Albireo Pharma
Renexxion
Global Constipation Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Constipation Treatment market, Segment by Type:
Chronic Idiopathic Constipation
Irritable Bowel Syndrome with Constipation
Opioid Induced Constipation
Global Constipation Treatment market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Constipation Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Constipation Treatment
1.1 Constipation Treatment Market Overview
1.1.1 Constipation Treatment Product Scope
1.1.2 Constipation Treatment Market Status and Outlook
1.2 Global Constipation Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Constipation Treatment Market Size by Region (2018-2029)
1.4 Global Constipation Treatment Historic Market Size by Region (2018-2023)
1.5 Global Constipation Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Constipation Treatment Market Size (2018-2029)
1.6.1 North America Constipation Treatment Market Size (2018-2029)
1.6.2 Europe Constipation Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Constipation Treatment Market Size (2018-2029)
1.6.4 Latin America Constipation Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Constipation Treatment Market Size (2018-2029)
2 Constipation Treatment Market by Type
2.1 Introduction
2.1.1 Chronic Idiopathic Constipation
2.1.2 Irritable Bowel Syndrome with Constipation
2.1.3 Opioid Induced Constipation
2.2 Global Constipation Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Constipation Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Constipation Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Constipation Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Constipation Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Constipation Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Constipation Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Constipation Treatment Revenue Breakdown by Type (2018-2029)
3 Constipation Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Constipation Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Constipation Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Constipation Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Constipation Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Constipation Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Constipation Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Constipation Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Constipation Treatment Revenue Breakdown by Application (2018-2029)
4 Constipation Treatment Competition Analysis by Players
4.1 Global Constipation Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Constipation Treatment as of 2022)
4.3 Date of Key Players Enter into Constipation Treatment Market
4.4 Global Top Players Constipation Treatment Headquarters and Area Served
4.5 Key Players Constipation Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Constipation Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Takeda
5.1.1 Takeda Profile
5.1.2 Takeda Main Business
5.1.3 Takeda Constipation Treatment Products, Services and Solutions
5.1.4 Takeda Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Takeda Recent Developments
5.2 SGYP
5.2.1 SGYP Profile
5.2.2 SGYP Main Business
5.2.3 SGYP Constipation Treatment Products, Services and Solutions
5.2.4 SGYP Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 SGYP Recent Developments
5.3 Sucampo Pharmaceuticals
5.3.1 Sucampo Pharmaceuticals Profile
5.3.2 Sucampo Pharmaceuticals Main Business
5.3.3 Sucampo Pharmaceuticals Constipation Treatment Products, Services and Solutions
5.3.4 Sucampo Pharmaceuticals Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Ironwood Pharmaceuticals Recent Developments
5.4 Ironwood Pharmaceuticals
5.4.1 Ironwood Pharmaceuticals Profile
5.4.2 Ironwood Pharmaceuticals Main Business
5.4.3 Ironwood Pharmaceuticals Constipation Treatment Products, Services and Solutions
5.4.4 Ironwood Pharmaceuticals Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Ironwood Pharmaceuticals Recent Developments
5.5 Abbott
5.5.1 Abbott Profile
5.5.2 Abbott Main Business
5.5.3 Abbott Constipation Treatment Products, Services and Solutions
5.5.4 Abbott Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca Constipation Treatment Products, Services and Solutions
5.6.4 AstraZeneca Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 AstraZeneca Recent Developments
5.7 Cosmo Pharmaceuticals
5.7.1 Cosmo Pharmaceuticals Profile
5.7.2 Cosmo Pharmaceuticals Main Business
5.7.3 Cosmo Pharmaceuticals Constipation Treatment Products, Services and Solutions
5.7.4 Cosmo Pharmaceuticals Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Cosmo Pharmaceuticals Recent Developments
5.8 Sanofi
5.8.1 Sanofi Profile
5.8.2 Sanofi Main Business
5.8.3 Sanofi Constipation Treatment Products, Services and Solutions
5.8.4 Sanofi Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Recent Developments
5.9 Daewoong
5.9.1 Daewoong Profile
5.9.2 Daewoong Main Business
5.9.3 Daewoong Constipation Treatment Products, Services and Solutions
5.9.4 Daewoong Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Daewoong Recent Developments
5.10 Bayer
5.10.1 Bayer Profile
5.10.2 Bayer Main Business
5.10.3 Bayer Constipation Treatment Products, Services and Solutions
5.10.4 Bayer Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Bayer Recent Developments
5.11 Prestige Brands
5.11.1 Prestige Brands Profile
5.11.2 Prestige Brands Main Business
5.11.3 Prestige Brands Constipation Treatment Products, Services and Solutions
5.11.4 Prestige Brands Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Prestige Brands Recent Developments
5.12 Janssen Pharmaceutical
5.12.1 Janssen Pharmaceutical Profile
5.12.2 Janssen Pharmaceutical Main Business
5.12.3 Janssen Pharmaceutical Constipation Treatment Products, Services and Solutions
5.12.4 Janssen Pharmaceutical Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Janssen Pharmaceutical Recent Developments
5.13 Shionogi
5.13.1 Shionogi Profile
5.13.2 Shionogi Main Business
5.13.3 Shionogi Constipation Treatment Products, Services and Solutions
5.13.4 Shionogi Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Shionogi Recent Developments
5.14 Albireo Pharma
5.14.1 Albireo Pharma Profile
5.14.2 Albireo Pharma Main Business
5.14.3 Albireo Pharma Constipation Treatment Products, Services and Solutions
5.14.4 Albireo Pharma Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.14.5 Albireo Pharma Recent Developments
5.15 Renexxion
5.15.1 Renexxion Profile
5.15.2 Renexxion Main Business
5.15.3 Renexxion Constipation Treatment Products, Services and Solutions
5.15.4 Renexxion Constipation Treatment Revenue (US$ Million) & (2018-2023)
5.15.5 Renexxion Recent Developments
6 North America
6.1 North America Constipation Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Constipation Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Constipation Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Constipation Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Constipation Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Constipation Treatment Market Dynamics
11.1 Constipation Treatment Industry Trends
11.2 Constipation Treatment Market Drivers
11.3 Constipation Treatment Market Challenges
11.4 Constipation Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
